<?xml version="1.0" encoding="UTF-8"?>
<eudamedExport entity="devices">
  <row>
    <udiDi>08682476905618</udiDi>
    <basicUdiDi>B-08682476905618</basicUdiDi>
    <tradeName>NoeChondrO</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVC3X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:40.889Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905601</udiDi>
    <basicUdiDi>B-08682476905601</basicUdiDi>
    <tradeName>NoeChondrO</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVC2X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:36.822Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905595</udiDi>
    <basicUdiDi>B-08682476905595</basicUdiDi>
    <tradeName>NoeChondrO</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid and Chondroitin Sulfate %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVCS3X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:36.045Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905588</udiDi>
    <basicUdiDi>B-08682476905588</basicUdiDi>
    <tradeName>NoeChondrO</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid and Chondroitin Sulfate %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVCS2X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:35.216Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905571</udiDi>
    <basicUdiDi>B-08682476905571</basicUdiDi>
    <tradeName>NoevisC</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVC3X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:34.421Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905564</udiDi>
    <basicUdiDi>B-08682476905564</basicUdiDi>
    <tradeName>NoevisC</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVC2X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:30.435Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905557</udiDi>
    <basicUdiDi>B-08682476905557</basicUdiDi>
    <tradeName>NoevisC</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid And Chondroitin Sulfate %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVCS3X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:29.629Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905540</udiDi>
    <basicUdiDi>B-08682476905540</basicUdiDi>
    <tradeName>NoevisC</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid And Chondroitin Sulfate %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVCS2X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:28.818Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905533</udiDi>
    <basicUdiDi>B-08682476905533</basicUdiDi>
    <tradeName>ZerrE</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVC3X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:28.014Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905526</udiDi>
    <basicUdiDi>B-08682476905526</basicUdiDi>
    <tradeName>ZerrE</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVC2X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:24.012Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905519</udiDi>
    <basicUdiDi>B-08682476905519</basicUdiDi>
    <tradeName>ZerrE</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid and Chondroitin Sulfate %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVCS3X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:23.212Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905502</udiDi>
    <basicUdiDi>B-08682476905502</basicUdiDi>
    <tradeName>ZerrE</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid and Chondroitin Sulfate %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVCS2X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:22.408Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905496</udiDi>
    <basicUdiDi>B-08682476905496</basicUdiDi>
    <tradeName>NoevisC X</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVC3X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:21.612Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905489</udiDi>
    <basicUdiDi>B-08682476905489</basicUdiDi>
    <tradeName>NoevisC X</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode></emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVC2X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:06.330Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905472</udiDi>
    <basicUdiDi>B-08682476905472</basicUdiDi>
    <tradeName>NoevisC X</tradeName>
    <deviceName></deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>UNKNOWN</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVCS3X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:05.533Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905465</udiDi>
    <basicUdiDi>B-08682476905465</basicUdiDi>
    <tradeName>NoevisC X</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid and Chondroitin Sulfate %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVCS2X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:04.745Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905458</udiDi>
    <basicUdiDi>B-08682476905458</basicUdiDi>
    <tradeName>NoetriX</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVC3X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:03.941Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905441</udiDi>
    <basicUdiDi>B-08682476905441</basicUdiDi>
    <tradeName>NoetriX</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVC2X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:50:03.149Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905434</udiDi>
    <basicUdiDi>B-08682476905434</basicUdiDi>
    <tradeName>NoetriX</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid and Chondroitin Sulfate %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVCS3X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:49:59.150Z</lastUpdated>
  </row>
  <row>
    <udiDi>08682476905427</udiDi>
    <basicUdiDi>B-08682476905427</basicUdiDi>
    <tradeName>NoetriX</tradeName>
    <deviceName>Sterile Intra-Articular Injection With Hyaluronic Acid and Chondroitin Sulfate %2</deviceName>
    <manufacturerName>NOEGENIX SAGLIK A.S</manufacturerName>
    <manufacturerSrn>TR-MF-000019020</manufacturerSrn>
    <authorisedRepresentativeName></authorisedRepresentativeName>
    <authorisedRepresentativeSrn></authorisedRepresentativeSrn>
    <riskClass>Sınıf III</riskClass>
    <legislation>MDD</legislation>
    <emdnCode>P900402</emdnCode>
    <emdnDescription>RESORBABLE FILLING AND RECONSTRUCTION DEVICES</emdnDescription>
    <deviceStatus>Piyasada</deviceStatus>
    <reference>NGXVCS2X2</reference>
    <placedOnMarketCountry>Türkiye</placedOnMarketCountry>
    <lastUpdated>2026-08-04T05:49:58.343Z</lastUpdated>
  </row>
</eudamedExport>